Laronde is pioneering a platform that offers a completely novel way of modulating human biology via Endless RNA™ (eRNA). eRNA is a uniquely engineered RNA that can be programmed to express diverse proteins inside the body. Laronde is rapidly scaling to support the development of multiple programs across many disease areas.
Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. Laronde has a highly collaborative, dedicated culture, driven to achieve our vision of “making eRNA an essential class of medicines to everyone, everywhere”. To learn more, please visit the company’s website at https://www.laronde.bio.
Laronde is seeking an outstanding Research Associate /Senior Research Associate, Molecular Cell Biology to join a multidisciplinary team of experimental and synthetic biologists responsible for study, design, and screening of novel endless RNA (eRNA) therapeutics. The ideal candidate will lead experimental efforts to generate and investigate arrayed eRNAs in vitro and in living cells in a high-throughput manner through applying the world-class molecular tools coupled with in cyto biology technologies.
If you are a passionate and purposeful researcher keen on testing your hypotheses and learning from some of the best synthetic biologists and molecular biologists, then we are looking for you.
Laronde is committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
Recruitment & Staffing Agencies: Laronde does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Laronde or its employees is strictly prohibited unless contacted directly by Laronde’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Laronde, and Laronde will not owe any referral or other fees with respect thereto